278 related articles for article (PubMed ID: 1622414)
1. Isolated diffusing capacity reduction in systemic sclerosis.
Steen VD; Graham G; Conte C; Owens G; Medsger TA
Arthritis Rheum; 1992 Jul; 35(7):765-70. PubMed ID: 1622414
[TBL] [Abstract][Full Text] [Related]
2. Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?
Corzo P; Pros A; Martinez-Llorens J; Molina L; Ling SF; Balcells E
Clin Rheumatol; 2018 Dec; 37(12):3365-3371. PubMed ID: 30368639
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline.
Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Lumetti F; Luppi F; Cerri S; Ferri C
Reumatismo; 2015 Dec; 67(4):149-55. PubMed ID: 27215180
[TBL] [Abstract][Full Text] [Related]
4. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
Goh NS; Hoyles RK; Denton CP; Hansell DM; Renzoni EA; Maher TM; Nicholson AG; Wells AU
Arthritis Rheumatol; 2017 Aug; 69(8):1670-1678. PubMed ID: 28426895
[TBL] [Abstract][Full Text] [Related]
5. Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
Le Gouellec N; Duhamel A; Perez T; Hachulla AL; Sobanski V; Faivre JB; Morell-Dubois S; Lambert M; Hatron PY; Hachulla E; Béhal H; Matran R; Launay D; Remy-Jardin M
PLoS One; 2017; 12(8):e0181692. PubMed ID: 28763468
[TBL] [Abstract][Full Text] [Related]
6. Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.
Ninagawa K; Kato M; Nakamura H; Abe N; Kono M; Fujieda Y; Oku K; Yasuda S; Ohira H; Tsujino I; Atsumi T
Rheumatol Int; 2019 Nov; 39(11):1883-1887. PubMed ID: 31280357
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
[TBL] [Abstract][Full Text] [Related]
8. Increase of pulmonary diffusing capacity in systemic sclerosis.
Dujić Z; Eterović D; Tocilj J; Andjelinović D
Br J Rheumatol; 1994 May; 33(5):437-41. PubMed ID: 8173847
[TBL] [Abstract][Full Text] [Related]
9. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and pathophysiological marker for patients with chronic thromboembolic pulmonary hypertension: Usefulness of diffusing capacity for carbon monoxide at diagnosis.
Suda R; Tanabe N; Ishida K; Kato F; Urushibara T; Sekine A; Nishimura R; Jujo T; Sugiura T; Shigeta A; Sakao S; Tatsumi K
Respirology; 2017 Jan; 22(1):179-186. PubMed ID: 27614712
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pulmonary complications and long-term survival in systemic sclerosis.
Nihtyanova SI; Schreiber BE; Ong VH; Rosenberg D; Moinzadeh P; Coghlan JG; Wells AU; Denton CP
Arthritis Rheumatol; 2014 Jun; 66(6):1625-35. PubMed ID: 24591477
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.
Caron M; Hoa S; Hudson M; Schwartzman K; Steele R
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29769294
[TBL] [Abstract][Full Text] [Related]
13. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
15. Can we predict the severity of pulmonary hypertension in patients with scleroderma?
Acosta Colmán MI; Avila Pedretti G; Acosta ME; Simeón Aznar CP; Fonollosa Plá V; Villardel Torrés M
Reumatol Clin; 2012; 8(5):259-62. PubMed ID: 22658662
[TBL] [Abstract][Full Text] [Related]
16. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease.
Someya F; Mugii N; Hasegawa M; Yahata T; Nakagawa T
Respir Care; 2014 Jan; 59(1):75-80. PubMed ID: 23764864
[TBL] [Abstract][Full Text] [Related]
17. Utility of FVC/DLCO ratio to stratify the risk of mortality in unselected subjects with pulmonary hypertension.
Donato L; Giovanna Elisiana C; Giuseppe G; Pietro S; Michele C; Brunetti ND; Valentina V; Matteo DB; Maria Pia FB
Intern Emerg Med; 2017 Apr; 12(3):319-326. PubMed ID: 27888395
[TBL] [Abstract][Full Text] [Related]
18. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.
Steen V; Medsger TA
Arthritis Rheum; 2003 Feb; 48(2):516-22. PubMed ID: 12571862
[TBL] [Abstract][Full Text] [Related]
19. Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis.
Sivova N; Launay D; Wémeau-Stervinou L; De Groote P; Remy-Jardin M; Denis G; Lambert M; Lamblin N; Morell-Dubois S; Fertin M; Lefevre G; Sobanski V; Le Rouzic O; Hatron PY; Wallaert B; Hachulla E; Perez T
PLoS One; 2013; 8(10):e78001. PubMed ID: 24205063
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis.
Hudson M; Assayag D; Caron M; Fox BD; Hirsch A; Steele R; Gaudreau-Taillefer R; Tatibouet S; ; Rudski L; Baron M
Clin Rheumatol; 2013 Oct; 32(10):1467-74. PubMed ID: 23733274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
